C07D 307/79
With only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to
Official title: with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
C07D307/79 (With only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to) appears on 1,856 US grants and 1,557 published applications in this corpus.
Search patents in C07D- Granted patents
- 1,856
- Published applications
- 1,557
- Assignees
- 839
- Inventors
- 5,660
- Latest grant
- 22 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 34 | 0 |
| 1977 | 25 | 0 |
| 1978 | 31 | 0 |
| 1979 | 25 | 0 |
| 1980 | 21 | 0 |
| 1981 | 17 | 0 |
| 1982 | 9 | 0 |
| 1983 | 13 | 0 |
| 1984 | 14 | 0 |
| 1985 | 15 | 0 |
| 1986 | 22 | 0 |
| 1987 | 25 | 0 |
| 1988 | 20 | 0 |
| 1989 | 35 | 0 |
| 1990 | 27 | 0 |
| 1991 | 29 | 0 |
| 1992 | 29 | 0 |
| 1993 | 29 | 0 |
| 1994 | 24 | 0 |
| 1995 | 33 | 0 |
| 1996 | 29 | 0 |
| 1997 | 53 | 0 |
| 1998 | 51 | 0 |
| 1999 | 47 | 0 |
| 2000 | 42 | 0 |
| 2001 | 55 | 13 |
| 2002 | 50 | 42 |
| 2003 | 45 | 73 |
| 2004 | 46 | 104 |
| 2005 | 34 | 95 |
| 2006 | 61 | 94 |
| 2007 | 40 | 68 |
| 2008 | 50 | 75 |
| 2009 | 60 | 83 |
| 2010 | 58 | 76 |
| 2011 | 40 | 48 |
| 2012 | 44 | 72 |
| 2013 | 51 | 66 |
| 2014 | 57 | 61 |
| 2015 | 56 | 60 |
| 2016 | 55 | 63 |
| 2017 | 45 | 48 |
| 2018 | 49 | 45 |
| 2019 | 37 | 45 |
| 2020 | 41 | 50 |
| 2021 | 42 | 44 |
| 2022 | 28 | 39 |
| 2023 | 31 | 48 |
| 2024 | 25 | 58 |
| 2025 | 43 | 52 |
| 2026 | 14 | 35 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Tautomeric ligand enables biomimetic C—H hydroxylation with molecular oxygen22 Sep 2026US 12,741,937 B2The Scripps Research Institute
- Anthracene compound and organic light-emitting device comprising same21 Jul 2026US 12,690,387 B2Sfc Co., Ltd.
- Chemical compounds and uses thereof23 Jun 2026US 12,662,451 B2Glaxosmithkline Intellectual Property (No. 4) Ltd.
- Small molecules with antibacterial activity16 Jun 2026US 12,655,101 B2New Mexico Tech University Research Park Corporation
- Arylamides and methods of use thereof26 May 2026US 12,637,414 B2Genzyme Corporation
- Organic Photoredox Catalysts, Compositions, and Conversion Processes24 Sep 2026US 2026/0284647 A1Colorado State University Research Foundation
- Materials for electronic devices3 Sep 2026US 2026/0262375 A1Merck Patent GmbH
- 3-aryloxy-3-aryl-propylamine compound and uses thereof20 Aug 2026US 2026/0242364 A1Shanghai Leado Pharmatech Co. Ltd.
- Methods for determining drug candidates20 Aug 2026US 2026/0245655 A1Mosaiques Diagnostics and Therapeutics AG
- Catalyst for sp3-carbon-hydrogen-bond primary amination reaction, and method for preparing primary amine compound13 Aug 2026US 2026/0234096 A1West China Second University Hospital, Sichuan University
Most cited
By later US patents
- Fluorescent indicator dyes for calcium ions238US 4,603,209 AThe Regents of the University of California · 1986
- Diaryl bicyclic heterocycles as inhibitors of cyclooxygenase-2192US 5,521,213 AMerck Frosst Canada, Inc. · 1996
- Benzo (b) thiophene carboxylate derivatives and pharmaceutical compositions182US 4,740,519 ACentre International de Recherches Dermatologiques (C.I.R.D.) · 1988
- Spiro compounds and their use as electroluminescence materials179US 5,840,217 AHoechst Aktiengesellschaft · 1998
- Prostaglandin synthase inhibitors169US 5,593,994 AThe DuPont Merck Pharmaceutical Company · 1997